1. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020; 21(11): 4012.
2. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018; 10: 239–48.
3. Kuo WH, Huang CY, Fu C, Hsieh YH, Li CH, Hsu CM, et al. Effects of Interleukin-10 Polymorphisms and Smoking on the Risk of Gastric Cancer in Taiwan. in vivo. 2014; 28: 967-972.
4. Ramis IB, Vianna JS, Gonçalves CV, von Groll A, Dellagostin OA, da Silva PEA. Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori. J Microbiol Immunol Infect. 2017; 50(2): 153–9.
5. Kim J, Cho YA, Choi IJ, Lee Y-S, Kim S-Y, Shin A, et al. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One. 2012; 7(1): e29643.
6. McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014; 11(11): 664–74.
7. Ouyang W, O’Garra A. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation. Immunity. 2019; 50(4): 871–91.
8. Quan X, Ding Y, Feng R, Zhu X, Zhang Q. Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray. Oncol Lett. 2017; 14(6): 7360–6.
9. Diaz Orea MA, Muñoz Perez V, Gómez Conde E, Castellanos Sánchez VO, Gonzalez Lopez R, Flores Alonso JC, et al. Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican Patients. Asian Pac J Cancer Prev. 2017; 18(2): 577–82.
10. Mohamed HT, El-Husseiny N, El-Ghonaimy EA, Ibrahim SA, Bazzi ZA, Cavallo-Medved D, et al. . IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: the potential role of tumor infiltrated macrophages. Curr Probl Cancer. 2018; 42: 215–230.
11. Kindlund B, Sjöling Å, Yakkala C, Adamsson J, Janzon A, Hansson L-E, et al. CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. Gastric Cancer. 2017; 20(1): 116–25.
12. Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015; 367(2): 103–7.
13. Yu Z, Liu Q, Huang C, Wu M, Li G. The interleukin 10 −819C/T polymorphism and cancer risk: A HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS. 2013; 17: 200–214.
14. Mirfakhar F, Mohebi S, Azimzadeh P. Association between interleukin 10 gene polymorphism (rs1800872A/C) and chronic hepatitis B infection. Razi J Med Sci. 2017; 23(144): 91–9.
15. Dai Z-J, Wang X-J, Zhao Y, Ma X-B, Kang H-F, Min W-L, et al. Effects of interleukin-10 polymorphisms (rs1800896, rs1800871, and rs1800872) on breast cancer risk: evidence from an updated meta-analysis. Genet Test Mol Biomarkers. 2014; 18(6): 439–45.
16. Sabet S, El-Sayed SK, Mohamed HT, El-Shinawi M, Mohamed MM. Inflammatory breast cancer: high incidence of GC haplotypes (−1082A/G, −819T/C, and −592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients carcinoma tissues. Tumor Biol. 2017: 1-11.
17. Martinez-Compos C, Torres-Poveda K, Camorlinga-Ponce M, Flores-Luna L, Maldonado-Bernal C, Madrid-Marina V, et al. Polymorphisms in IL-10 and TGF-B gene promoter areassociated with lower risk to gastric cancer in a Mecxican population. BMC cancer. 2019; 19: 453-461.
18. Namazi A, Forat yazdi M, Jafari MA, Farahnak S, Nasiri R, Foroughi E, et al. Association of interleukin-10 -1082 A/G (rs1800896) polymorphism with susceptibility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol. 2018; 55(1); 33-40.
19. Li C, Tong W, Liu B, Zhang A, Li F. The -1082A.G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysis. Sci Rep. 2014; 4(5335): 1-7.
20. Pan XF, Yang SJ, Loh M, Xie Y, Wen YY, Tian Z, et al. Interleukin-10 Gene Promoter Polymorphisms and Risk of Gastric Cancer in a Chinese Population: Single Nucleotide and Haplotype Analyses. Asian Pacific J Cancer Prev. 2013; 14 (4): 2577-2582.
21. Wangy J, Dingy Q, Shiy Y, Cao Q, Qin C, Zhu J, et al. The interleukin-10-1082 promoter
polymorphism and cancer risk: a meta-analysis. Mutagenesis. 2012; 27(3): 305–312.
22. Chand-Bhayal A, Krishnaveni D, Pandu-Ranga-Rao K, Prabhakar B, Vidyasagar A, Murali-Krishna B, et al. Association of interleukin-10 promoter polymorphism (-1082 g/a) and gastric cancer in andhra pradesh population of South India. Iran J cancer Prev. 2012; 5(3): 117–23.
23. Peihua Ni P, Xu H, Xue H, Lin B, Lu Y. A Meta-Analysis of Interleukin-10-1082 Promoter Polymorphism Associated with Gastric Cancer Risk. DNA Cell Bio. 2012; 31(4): 582-591.
24. Fei C, Yao XM, Sun Y, Gu XZ, Yu LQ, Lai X. Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia. Genet Mol Res. 2015; 14(1): 925–30.
25. Yang Y, Fa X. Role of IL-10 gene polymorphisms on the susceptibility for esophageal cancer and its association with environmental factors. Int J Clin Exp Pathol. 2015; 8(8): 9580–5.
26. Zhu ZY, Liu JB, Liu X, Qia LX. Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis. J Int Med Res. 2020; 48(4): 1–14.
27. Jaradat S, Ababneh K, Jaradat S, Abbadi M, Taha A, Karasneh J, et al. Association of interleukin-10 gene promoter polymorphisms with chronic and aggressive periodontitis. Oral Dis. 2012; 18(3): 271–9.